Who Holds BridgeBio Oncology Therapeutics, Inc. (BBOT)? 66 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 66 holders, $448 million in total.
Largest holders
The 66 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 17,878,594 | $136 million | +0% | 13F |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 4,885,446 | $37 million | +0% | 13F |
| Omega Fund Management, LLC | 3,289,661 | $25 million | +0% | 13F |
| Alphabet Inc. | 2,823,126 | $22 million | +0% | 13F |
| EcoR1 Capital, LLC | 2,823,126 | $22 million | +0% | 13F |
| WELLINGTON MANAGEMENT GROUP LLP | 2,789,302 | $21 million | -1% | 13F |
| ENAVATE SCIENCES GP, LLC | 2,626,946 | $20 million | +0% | 13F |
| CITADEL ADVISORS LLC | 2,617,827 | $20 million | +4% | 13F |
| NOVO HOLDINGS A/S | 2,250,000 | $17 million | +3% | 13F |
| BlackRock, Inc. | 2,154,040 | $16 million | +3% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,005,649 | $15 million | +272% | 13F |
| Laurion Capital Management LP | 2,002,701 | $15 million | +4% | 13F |
| ARMISTICE CAPITAL, LLC | 1,764,000 | $13 million | +33% | 13F |
| STATE STREET CORP | 1,036,569 | $8 million | +358% | 13F |
| Aisling Capital Management LP | 1,018,018 | $8 million | +0% | 13F |
| Opaleye Management Inc. | 700,000 | $5 million | +1214% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 622,351 | $5 million | +7% | 13F |
| Granahan Investment Management, LLC | 558,526 | $4 million | +142% | 13F |
| SPHERA FUNDS MANAGEMENT LTD. | 460,985 | $4 million | New | 13F |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 400,000 | $3 million | +0% | 13F |
| ROYCE & ASSOCIATES LP | 384,941 | $3 million | -40% | 13F |
| Catalio Capital Management, LP | 318,407 | $2 million | New | 13F |
| VANGUARD FIDUCIARY TRUST CO | 291,522 | $2 million | +15% | 13F |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 286,518 | $2 million | -1% | 13F |
| Casdin Capital, LLC | 282,312 | $2 million | +0% | 13F |
| Ensign Peak Advisors, Inc | 273,530 | $2 million | -15% | 13F |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 244,441 | $2 million | -2% | 13F |
| FMR LLC | 240,587 | $2 million | +0% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 191,152 | $1 million | +110% | 13F |
| NORTHERN TRUST CORP | 186,482 | $1 million | +82% | 13F |
| Sio Capital Management, LLC | 130,628 | $995,385 | +0% | 13F |
| UBS Group AG | 114,655 | $873,671 | +127% | 13F |
| MILLENNIUM MANAGEMENT LLC | 105,480 | $803,758 | -60% | 13F |
| GOLDMAN SACHS GROUP INC | 102,085 | $777,888 | -39% | 13F |
| MOORE CAPITAL MANAGEMENT, LP | 100,000 | $762,000 | +0% | 13F |
| Tidal Investments LLC | 93,339 | $711,243 | +14% | 13F |
| Tema ETFs LLC | 93,339 | $711,243 | +14% | 13F |
| Brevan Howard Capital Management LP | 88,895 | $690,714 | +524% | 13F |
| Palumbo Wealth Management LLC | 85,624 | $652,455 | New | 13F |
| BANK OF AMERICA CORP /DE/ | 77,140 | $587,807 | New | 13F |
| Jump Financial, LLC | 62,000 | $472,440 | New | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 58,600 | $446,532 | -42% | 13F |
| Avidity Partners Management LP | 43,853 | $334,160 | +0% | 13F |
| TD Asset Management Inc | 42,730 | $325,603 | -26% | 13F |
| Virtus Investment Advisers, LLC | 42,220 | $321,716 | New | 13F |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 27,984 | $213,238 | -22% | 13F |
| TWO SIGMA INVESTMENTS, LP | 26,485 | $201,816 | New | 13F |
| Rafferty Asset Management, LLC | 22,606 | $172,258 | New | 13F |
| CITIGROUP INC | 19,872 | $151,425 | New | 13F |
| Squarepoint Ops LLC | 19,662 | $149,824 | -54% | 13F |
| Vanguard Global Advisers, LLC | 18,163 | $138,402 | +0% | 13F |
| Schonfeld Strategic Advisors LLC | 11,504 | $87,659 | New | 13F |
| PROFUND ADVISORS LLC | 11,001 | $83,828 | New | 13F |
| AXQ CAPITAL, LP | 10,728 | $81,747 | -38% | 13F |
| MORGAN STANLEY | 3,380 | $25,755 | -92% | 13F |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2,626 | $20,115 | New | 13F |
| BARCLAYS PLC | 2,099 | $15,995 | +890% | 13F |
| Tower Research Capital LLC (TRC) | 1,696 | $12,924 | New | 13F |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 1,350 | $10,287 | New | 13F |
| Rockefeller Capital Management L.P. | 1,000 | $7,620 | +43% | 13F |
| Integrated Wealth Concepts LLC | 437 | $3,330 | New | 13F |
| WELLS FARGO & COMPANY/MN | 300 | $2,286 | +0% | 13F |
| PRICE T ROWE ASSOCIATES INC /MD/ | 300,000 | $2,286 | -31% | 13F |
| Quarry LP | 197 | $1,501 | New | 13F |
| Caitong International Asset Management Co., Ltd | 37 | $282 | +825% | 13F |
| Pacer Advisors, Inc. | 378 | $3 | New | 13F |
Questions and answers
- How many institutions hold BridgeBio Oncology Therapeutics, Inc.?
- 66 managers reported BridgeBio Oncology Therapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 67 the quarter before.
- Who is the largest institutional holder of BridgeBio Oncology Therapeutics, Inc.?
- Cormorant Asset Management, LP, with 17,878,594 shares worth $136 million on its 13F for Q2 2026.
- How many institutions bought or sold out of BridgeBio Oncology Therapeutics, Inc. in Q2 2026?
- 17 managers reported a new position and 18 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds BridgeBio Oncology Therapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/bridgebio-oncology-therapeutics, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.